Evofem Biosciences, Inc. ( EVFM) - Key Metrics
EVFM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$0.08 | -$0.02 | -$0.02 |
| 2026Q1 | $0.01 | -$0.04 | $0.02 | $0.02 |
| 2025Q4 | $0.08 | $0.02 | $0 | $0 |
| 2025Q3 | $0.04 | -$0.01 | $0 | $0 |
| 2025Q2 | $0.04 | -$0.02 | -$0.03 | -$0.03 |
EVFM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -0.98% | -0.02 |
| 2026Q1 | -0.36% | -0.05 |
| 2025Q4 | 0.07% | 0.11 |
| 2025Q3 | -7.07% | -0.22 |
| 2025Q2 | -0.06% | -0.16 |
EVFM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -286.87% | 9.87% |
| 2026Q1 | 196.06% | 1.71% |
| 2025Q4 | 2.38% | 0.17% |
| 2025Q3 | 23.22% | 7.67% |
| 2025Q2 | -257.65% | 0.09% |
EVFM
Price: $0.01
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.05 USD
P/E Ratio: -0.18
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.6 million
Ebitda: -1.8 millionMarket Capitalization: 980722